Previous Close | 110.15 |
Open | 109.80 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's Range | 109.65 - 109.85 |
52 Week Range | 89.06 - 121.75 |
Volume | |
Avg. Volume | 1 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
HOYA Group Company, PENTAX of America, Inc. (PENTAX Medical) and MAGENTIQ-EYE Ltd., an AI medical device company, announced today their intention to form a partnership in the field of AI in Gastroenterology and to examine further collaboration and strategic partnerships.
Ophthalmic lens technology leader HOYA Vision Care announced today the Canadian launch of its Super HiVision® Meiryo™ EX4™ anti-reflective treatment, advancing HOYA's legacy of 60 years in AR coating innovation. The new lens treatment offers industry-leading scratch resistance, durability, and long-term cleanability as well as complete back-side UV protection that eye care providers and patients have come to expect.
HOYA Group, PENTAX Medical announced an agreement with IRCAD, the international advanced research and training center in minimally invasive surgery based in Strasbourg, France to collaborate in education for physicians to learn advanced flexible endoscopy. IRCAD offers a training facility, which welcomes over 8,800 worldwide surgeons from all surgical and GI specialties every year. The training and research institute involves more than 800 international experts in their training centers. It is a